Going from an O/S of 200MM to well over 400MM since last October is neither conservative or responsible. Only 18% of a recent biotech sector index (that included VDRM) had over 200MM in O/S, muck less diluted to that number in a year.
None sense.. Every bit of news has been the perfect opportunity to dump more share. Bluff news. As I stated yesterday, this thing aint going anywhere but down. If sales are on the horizon, why dilute now? Nothing makes sense..
Market Data 
Markets 
AI
